Key facts
- This page summarizes Eric Thomas Schmidt's Form 4 filing for Revolution Medicines, Inc. (RVMD).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 12 Jun 2023, 16:14.
Eric Thomas Schmidt - 08 Jun 2023 Form 4 Insider Report for Revolution Medicines, Inc. (RVMD)
- Reporting relationship
- Director
- Issuer ticker
- RVMD
- Reported as of
- 08 Jun 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 12 Jun 2023, 16:14:49 UTC
- Prior SEC filing
- 30 May 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jack Anders, as Attorney-in-fact for Eric Schmidt
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Eric Thomas Schmidt filed Form 4 for Revolution Medicines, Inc. (RVMD) on 12 Jun 2023.
Change
- Previous filing in this sequence was filed on 30 May 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RVMD
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +5,200
- Change %
- +32%
- Price
- $0.000000
- Shares after
- 21,251
- Date
- 08 Jun 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
RVMD
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +18,400
- Change %
- Price
- $0.000000
- Shares after
- 18,400
- Date
- 08 Jun 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 18,400
- Exercise price
- $24.84
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Includes 6,406 Restricted Stock Units.
Footnote F2
Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 8, 2023 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date.